新闻
来自塑造行业的会议、展会和峰会的 医疗健康 领域最新新闻、公告和分析。
A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.
(opens original source in a new tab)Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.
(opens original source in a new tab)© 2026 Industry Events Worldwide。保留所有权利。
一封简短的邮件。汇集塑造全球商业的展会、会议和峰会的头条新闻。没有废话,没有垃圾邮件,随时可取消订阅。